Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19 (ECMO-COVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04343404
Recruitment Status : Completed
First Posted : April 13, 2020
Last Update Posted : June 29, 2020
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

Brief Summary:
Describe COVID-19 patients who are receiving ECMO-VV respiratory replacement and what happens to them.

Condition or disease
Respiratory Distress Syndrome

Layout table for study information
Study Type : Observational
Actual Enrollment : 100 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: STUDY ECMO-COVID-19 : Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19
Actual Study Start Date : April 1, 2020
Actual Primary Completion Date : April 15, 2020
Actual Study Completion Date : April 15, 2020





Primary Outcome Measures :
  1. Retrospective description of COVID-19 patients receiving respiratory ECMO-VV supplementation and what happens to them [ Time Frame: Files analysed retrospectily from March 1st, 2020 to April 15, 2020 will be examined ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Adult patients with a COVID-19 diagnosis by RT-PCR
Criteria

Inclusion Criteria:

  • Patient over the age of 18;
  • Diagnostic COVID-19 by RT-PCR;
  • Hospitalisation in resuscitation for the management of complications related to COVID-19
  • Implanted ECMO-VV during hospitalisation;
  • Patient agreeing to participate in the study

Exclusion Criteria:

  • Sujet under guardianship or trusteeship
  • Sujet under safeguard of justice

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04343404


Locations
Layout table for location information
France
Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67091
Sponsors and Collaborators
University Hospital, Strasbourg, France
Investigators
Layout table for investigator information
Study Director: Pierre-Emmanuel FALCOZ, MD, PhD Service de Chirurgie Thoracique Nouvel Hôpital Civl Hôpitaux Univesitaires de Strasbourg
Layout table for additonal information
Responsible Party: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT04343404    
Other Study ID Numbers: 7772
First Posted: April 13, 2020    Key Record Dates
Last Update Posted: June 29, 2020
Last Verified: April 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Strasbourg, France:
Respiratory Distress Syndrome
ARDS
SARS-COV-2
Extracorporeal membrane oxygenation
ECMO
Veno-venous ECMO
Additional relevant MeSH terms:
Layout table for MeSH terms
Respiratory Distress Syndrome, Newborn
Respiratory Distress Syndrome, Adult
Lung Diseases
Respiratory Tract Diseases
Respiration Disorders
Infant, Premature, Diseases
Infant, Newborn, Diseases